New
Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
DRUG ETF · BetaShares Global Healthcare ETF - Currency Hedged
The DRUG Exchange Traded Fund (ETF) is provided by BetaShares. It is built to track an index: Nasdaq Global ex-Australia Healthcare Index. The DRUG ETF provides physical exposure, so by buying it you actually own parts of all the 59 underlying holdings. This share class generates a stream of income by distributing dividends.
Real-time data unavailable for DRUG
LIVE
CLOSED
This fund is part ofWorld Health Care1M perf.-5.36%
Last price
N/A
1M perf.
-3.14%
1M flows
-€3.3M
AuM
€107M
E/R
0.57%
Rating
Not rated
ESG Consensus®
DRUG
N/A
Performance & flows
Segment for quartile rank
December 11, 2025 → March 11, 2026
Create a free account to view the flows graph
DRUG
A$8.64
+0.38%
World Health Care
-0.62%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -3.14%  | +0.38% | +4.81%  | +22.59%  | +35.82% | -4.72% | -0.81% | -0.81% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
3/11/2026
A$8.64
1D NAV change
-0.40%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
59
Inception date
8/4/2016
Jurisdiction
Australia
Distribution
Australia
Legal structure
Unit Investment Trust
Base currency
AUD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Benchmark
Nasdaq Global ex-Australia Healthcare Index
Asset class
Factors
N/A
Investment strategy
DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
WDHE
1M perf.
-6.63%
E/R
0.18%
IXJ
1M perf.
-6.62%
E/R
0.4%
IXJ
1M perf.
-4.74%
E/R
0.47%
XHC
1M perf.
-5.83%
E/R
0.66%
PBPH
1M perf.
-3.01%
E/R
0.13%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +0.38% | +4.81% | +22.59% | +35.82% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
64.92%
Switzerland
12.25%
United Kingdom
7.30%
France
3.24%
Denmark
3.21%
Japan
3.03%
Ireland
1.86%
Unavailable
0.44%
Other
3.75%
Sectors
Health Care
92.49%
Consumer Discretionary
1.61%
Unavailable
5.13%
Other
0.77%
Diversification
Total weight of top 15 holdings out of 59
Top 15 holdings
Data as of January 31, 2026
JOHNSON&JOHNSON
LILLY
ABBVIE
ROCHE
ASTRAZENECA
NOVARTIS
MERCK & CO INC
UNITEDHEALTH GRP
Create a free account to view top holdings
THERMO FISHER SCIENTIFIC
DK0062498333
AMGEN-T
ABBOTT LABS
INTUITIVE SURGICAL
GILEAD SCIENCES
DANAHER
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about DRUG ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
DRUG’s has a Final Sustainability Grade of either A+, A, or A-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
95.98% of holdings have positive scoring
4.47% of holdings have negative scoring
5.43%
77.21%
13.34%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Not rated
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
Nasdaq Global ex-Australia Healthcare Hedged AUD Net Total Return Index - AUD
Index ticker
NQXAUHHN Index
Index dividend policy
NTR
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
BetaShares
BetaShares ID Card
Number of funds
103
Total AuM
€39.72B
Expense ratio range
0.04% - 1.38%
Average expense ratio
0.5061%
Top 5 funds by BetaShares
| AuM | ||
|---|---|---|
A200 | Betashares Australia 200 ETF | €5.66B |
NDQ | BetaShares NASDAQ 100 ETF | €4.47B |
AAA | Betashares Australian High Interest Cash ETF | €3.05B |
BGBL | BetaShares Global Shares ETF | €2.23B |
ETHI | BetaShares Global Sustainability Leaders ETF | €2.15B |
Frequently asked questions about DRUG
What does BetaShares Global Healthcare ETF - Currency Hedged, DRUG, invest in?
DRUG is a Passive ETF. This ETF provides exposure to Global ex-Australia Health Care Equities.
Which benchmark or index does DRUG replicate?
DRUG tracks the Nasdaq Global ex-Australia Healthcare Hedged AUD Net Total Return Index - AUD, through a full replication replication method.
What is the Total Expense ratio (TER) of DRUG?
DRUG carries a total expense ratio (TER) of 0.57%, indicating the annual cost for holding the fund.
When was DRUG launched?
DRUG was introduced to the market on August 4, 2016. It trades on Australia
Who is the ETF issuer of DRUG?
BetaShares Global Healthcare ETF - Currency Hedged, DRUG, is provided by BetaShares. Learn more about BetaShares here.
What is the current assets under management (AUM) of DRUG?
DRUG oversees €107M in assets as of March 11, 2026.
How has DRUG performed lately?
Based on data from March 11, 2026, DRUG returned -3.14% over the past month, 0.38% over the last three months and -0.81% year-to-date.
What are the latest inflows or outflows for DRUG?
As of March 11, 2026, DRUG recorded net flows of -€3.2M over the last month and -€4.8M year-to-date.
Does DRUG distribute dividends?
DRUG follows a distributing dividend policy, meaning it pays out income to investors. As of March 11, 2026, its 12-month trailing yield was 0.40%.
What are the main country or region exposures of DRUG?
As of January 31, 2026, DRUG has significant geographic allocations in USA, Switzerland and United Kingdom.
In which sector or theme does DRUG invest in?
As of January 31, 2026, DRUG focuses largely on Health Care and Consumer Discretionary.
How many securities does DRUG hold and how diversified is it?
As of January 31, 2026, DRUG holds 59 positions in its portfolio, with 62.21% of assets concentrated in its top 15 holdings.
What are the main positions in DRUG?
As of January 31, 2026, DRUG top three holdings include JOHNSON&JOHNSON, LILLY and ABBVIE.
What is the base currency of DRUG?
The base currency of DRUG is AUD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
